Replies to post #81238 on PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Pathetic

They put out a press release for this bit of nothing but can’t get one out to explain the change of approach from pivotal 2b to 2b. They even issue this one without addressing the main glitch they’re aware of.

This is really looking incompetent.

[ace1234]

Nothing regarding Phase 2B, where's the Glitch in the system?

A planned PR for cell bank completion, but nothing for changing from Pivotal to Phase 2b.

Why?

Was it deliberately hidden? There is no way, that out there is a PR lost somewhere in cyberspace, that was supposed to inform everyone that we are now switching from Pivotal to Phase 2b.

Nothing. I'm a strong long here, but this looks very, very bad imo.

"PharmaCyte is working on an IND to submit to the FDA so that it can begin a clinical trial involving locally advanced, inoperable, non-metastatic pancreatic cancer and expects to submit its IND later this year. "

I told you so. Best bet is end of the year. Not end of Q1, maybe in the summer, but looking like Sept.-Nov.